Discussing both her time at Stanford and her recent book “Drift,” Rachel Maddow told a packed Memorial Auditorium that “my Stanford advice is to…get good at making good arguments…There will be a role in your life for assessing facts well and putting them in a structure that makes sense.”
A Stanford School of Medicine researcher has discovered an innovative way to engineer immune system cells to resist H.I.V. infection.
Recent research conducted by the Wender Group, consisting of 19 chemists as well as Stanford professor Paul Wender, could point to the existence of potential… Continue Reading »
Stanford researchers have determined that a preventative medication for HIV could be a cost-effective investment for men at high risk of contracting the virus.
Using a computer model of the hepatitis C disease, Stanford researchers have shown that two new drugs intended to target the virus are cost-effective for patients suffering from advanced hepatitis C, despite some significant side effects.
The most effective way to combat the spread of HIV spread by intravenous drug use is a combined program of drug substitution and anti-retroviral therapy for those already infected, according to a study conducted by Stanford University and the Veteran Affairs Palo Alto Health Care System.
The United States Solicitor General filed a “friend of the court” brief before the United States Supreme Court supporting Stanford in its intellectual property lawsuit against biotech firm Roche Molecular Systems, Inc. The case stemmed from a dispute between the University and Roche over the ownership of patents used in the company’s HIV test kits.